Armis Advisers’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Armis Advisers’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Sell	19,211 -30,525	-61%	-$371K	0.02%	444
2026 Q1	$597K	Buy	49,736 +27,200	+121%	+$381K	0.06%	219
2025 Q4	$319K	Buy	+22,536	New	+$339K	0.04%	316
2025 Q3	–	Sell	-50,085	Closed	-$887K	–	349
2025 Q2	$887K	Sell	50,085 -31,044	-38%	-$605K	0.07%	206
2025 Q1	$1.69M	Buy	81,129 +16,567	+26%	+$314K	0.16%	118
2024 Q4	$1.19M	Buy	+64,562	New	+$1.24M	0.15%	115

Other funds holding BTAL

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

FBT

First Bankers Trust Louisville, Kentucky $321M AUM 29.65% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SRCM

Signature Resources Capital Management Newport Beach, California $254M AUM 26.72% 1-Year Est. Return

Armis Advisers's BTAL Position: Q2 2026 in Review

Armis Advisers reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 61% in Q2 2026, selling an estimated $371K and leaving 19,211 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #444.

Armis Advisers first reported a position in BTAL in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.69M in Q1 2025. 6 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

Armis Advisers held 19,211 shares of AGF US Market Neutral Anti-Beta Fund worth $221K as of Q2 2026.
Armis Advisers sold 30,525 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $371K.
AGF US Market Neutral Anti-Beta Fund made up 0.02% of Armis Advisers's portfolio in Q2 2026, its #444 holding.
Armis Advisers first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 6 quarters since.
Armis Advisers's AGF US Market Neutral Anti-Beta Fund position peaked at $1.69M in Q1 2025.
6 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.